STOCK TITAN

CytoDyn shareholders elect five directors

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

At its November 20, 2026 annual meeting, CytoDyn Inc. (CYDY) stockholders elected five director nominees: Tanya Durkee Urbach, Lishomwa C. Ndhlovu, M.D., Ph.D., Karen J. Brunke, Ph.D., Ryan M. Dunlap and Stephen M. Simes. They will serve until the 2027 annual meeting and until successors are elected and qualified, or earlier death, resignation or removal.

Stockholders also approved CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending May 31, 2027, on an advisory basis, and approved named executive officer compensation on an advisory basis.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Votes for Tanya Durkee Urbach 414,695,411 votes Director election
Votes for Lishomwa C. Ndhlovu 432,454,527 votes Director election
Votes for Karen J. Brunke 430,245,377 votes Director election
Votes for Ryan M. Dunlap 432,734,124 votes Director election
Votes for Stephen M. Simes 432,202,700 votes Director election
Votes for CBIZ CPAs P.C. 761,073,421 votes Advisory vote on auditor selection for fiscal year ending May 31, 2027
Votes for named executive officer compensation 380,137,658 votes Advisory compensation vote
Broker Non-Votes regulatory
"Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
advisory basis regulatory
"approved, on an advisory basis"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were the CYDY say-on-pay vote results?

Stockholders approved named executive officer compensation on an advisory basis, with 380,137,658 votes for, 72,139,425 against, 10,717,930 abstentions and 309,846,577 broker non-votes.

How many votes supported CBIZ as CYDY's auditor?

761,073,421 votes were for CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending May 31, 2027; 5,773,455 votes were against and 5,994,714 were abstentions. The selection was approved on an advisory basis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false0001175680NONE00011756802026-11-202026-11-20

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 20, 2026

 

 

CytoDyn, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-49908

83-1887078

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1111 MAIN STREET, SUITE 660

 

VANCOUVER, Washington

 

98660

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 360 980-8524

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

None

 

N/A

 

N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

CytoDyn Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on November 20, 2026. On November 20, 2026, the Inspector of Election issued its final report certifying the final voting results for the Annual Meeting, which were as follows:

1. Election of Directors.

 

 

 

 

 

 

 

 

Nominee

 

For

 

Withheld

 

Broker Non-Votes

Tanya Durkee Urbach

 

414,695,411

 

48,299,604

 

309,846,575

Lishomwa C. Ndhlovu, M.D., Ph.D.

 

432,454,527

 

30,540,488

 

309,846,575

Karen J. Brunke, Ph.D.

 

430,245,377

 

32,749,638

 

309,846,575

Ryan M. Dunlap

 

432,734,124

 

30,260,891

 

309,846,575

Stephen M. Simes

 

432,202,700

 

30,792,315

 

309,846,575

 

The stockholders elected each of the Company’s director nominees to serve until the Company’s 2027 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation, or removal.

 

2. Advisory vote on selection of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending May 31, 2027.

 

For

 

Against

 

Abstentions

761,073,421

 

5,773,455

 

5,994,714

 

The stockholders approved, on an advisory basis, the selection of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending May 31, 2027.

 

3. Advisory vote on compensation of named executive officers.

 

 

 

 

 

 

 

For

 

Against

 

Abstentions

Broker Non-Votes

380,137,658

 

72,139,425

 

10,717,930

309,846,577

 

The stockholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers.

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CYTODYN INC.

 

 

 

 

Date:

November 20, 2026

By:

/s/ Tyler Blok

 

 

 

Tyler Blok
Chief Legal Officer and Corporate Secretary

 


Filing Exhibits & Attachments

1 document

Keep reading